PharmaLex

PharmaLex is a leading global provider of specialized services for the pharmaceutical, biotechnology, and medical device industries. Now a part of Cencora, a prominent global pharmaceutical solutions organization, PharmaLex has significantly expanded its suite of offerings. The company guides clients through the entire product lifecycle, from early strategic planning and non-clinical requirements to clinical development, regulatory submission processes, and post-approval maintenance and post-launch activities. With a team of over 3,000 professionals across 32 countries, representing 40 nationalities and speaking over 40 languages, the company boasts a multidisciplinary team of experts with extensive education, training, and real-world experience. This diverse expertise spans all therapeutic areas, allowing PharmaLex to provide deep scientific and strategic advice on drug development.

Founded in 1994, PharmaLex has a long history of supporting its clients in ensuring compliance with ever-evolving pharmaceutical regulations. The company has successfully completed over 30,000 projects for more than 600 clients worldwide. PharmaLex prides itself on its technology-elevated solutions, which empower its experts to make better decisions and drive efficiency gains for their clients. The firm's services include development consulting, regulatory affairs, quality management and compliance, and pharmacovigilance. By combining extensive global experience with the development of a cloud-based platform for life sciences automation and partnerships with leading technology vendors, PharmaLex is at the forefront of helping the pharmaceutical industry adopt innovative technologies. This focus on technology and a client-centric approach allows them to deliver tailor-made solutions that accelerate clients' ability to make effective business decisions and navigate the complexities of the global healthcare market.